MedPath
NMPA Approval

Teriparatide Injection

国药准字SJ20170032

September 10, 2024

S20170032

Drug Information

特立帕肽注射液

复泰奥

注射剂

20μg:80μl, 2.4ml/支

生物制品

September 10, 2024

September 9, 2029

Company Information

Applicant Company

Papendorpseweg 83,3528 BJ Utrecht, The Netherlands

Manufacturing Company

lilly france s.a.s.

2 rue du Colonel Lilly, 67640 Fegersheim, France.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

特立帕肽注射液 - NMPA 批准文号 | MedPath